Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 108 Pages
Report ld: 6083651
Request Sample
Customized Report
16-Denyprasterone Acetate Market Size(US$)

CAGR 2026-2032
5.1%
Market Size,2032
USD 101
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for 16-Denyprasterone Acetate was estimated to be worth US$ 72 million in 2025 and is projected to reach US$ 101 million, growing at a CAGR of 5.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on 16-Denyprasterone Acetate cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
16-Denyprasterone Acetate is a white crystalline powder with no odor or smell; Easy to dissolve in ethanol and methanol, insoluble in water; Stable in the air, it is an important intermediate for the synthesis of steroid hormone drugs. It can be used as raw material to manufacture adrenal cortex hormones (such as hydrocortisone, prednisone), glucocorticoid drugs, anabolic hormones, estrogen (male) hormones, progesterone drugs, etc.
The North American market for 16-Denyprasterone Acetate was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for 16-Denyprasterone Acetate was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for 16-Denyprasterone Acetate was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the 16-Denyprasterone Acetate market include Molekula, Hubei Fangtong Pharmaceutical, Hubei Dan'ao Pharmaceutical, Hubei Danjiangkou Kaitai Hormone, Hubei Zhuxi Humanwell Pharma, Hubei Minsheng Biopharmaceutical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for 16-Denyprasterone Acetate, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The 16-Denyprasterone Acetate market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding 16-Denyprasterone Acetate.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the 16-Denyprasterone Acetate manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents 16-Denyprasterone Acetate sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents 16-Denyprasterone Acetate sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 16-Denyprasterone Acetate Product Introduction
1.2 Global 16-Denyprasterone Acetate Market Size Forecast
1.2.1 Global 16-Denyprasterone Acetate Sales Value (2021–2032)
1.2.2 Global 16-Denyprasterone Acetate Sales Volume (2021–2032)
1.2.3 Global 16-Denyprasterone Acetate Sales Price (2021–2032)
1.3 16-Denyprasterone Acetate Market Trends & Drivers
1.3.1 16-Denyprasterone Acetate Industry Trends
1.3.2 16-Denyprasterone Acetate Market Drivers & Opportunities
1.3.3 16-Denyprasterone Acetate Market Challenges
1.3.4 16-Denyprasterone Acetate Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 16-Denyprasterone Acetate Players Revenue Ranking (2025)
2.2 Global 16-Denyprasterone Acetate Revenue by Company (2021–2026)
2.3 Global 16-Denyprasterone Acetate Sales Volume Ranking of Players (2025)
2.4 Global 16-Denyprasterone Acetate Sales Volume by Company (2021–2026)
2.5 Global 16-Denyprasterone Acetate Average Price by Company (2021–2026)
2.6 Key Manufacturers 16-Denyprasterone Acetate Manufacturing Base and Headquarters
2.7 Key Manufacturers 16-Denyprasterone Acetate Product Offerings
2.8 Key Manufacturers Start of Mass Production of 16-Denyprasterone Acetate
2.9 16-Denyprasterone Acetate Market Competitive Analysis
2.9.1 16-Denyprasterone Acetate Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by 16-Denyprasterone Acetate Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on 16-Denyprasterone Acetate revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation 16-Denyprasterone Acetate Market Classification
3.1 Introduction by Type
3.1.1 Purity ≥98%
3.1.2 Purity ≥99%
3.1.3 Global 16-Denyprasterone Acetate Sales Value by Type
3.1.3.1 Global 16-Denyprasterone Acetate Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global 16-Denyprasterone Acetate Sales Value, by Type (2021–2032)
3.1.3.3 Global 16-Denyprasterone Acetate Sales Value, by Type (%), 2021–2032
3.1.4 Global 16-Denyprasterone Acetate Sales Volume by Type
3.1.4.1 Global 16-Denyprasterone Acetate Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global 16-Denyprasterone Acetate Sales Volume, by Type (2021–2032)
3.1.4.3 Global 16-Denyprasterone Acetate Sales Volume, by Type (%), 2021–2032
3.1.5 Global 16-Denyprasterone Acetate Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Steroid Hormone Intermediates
4.1.2 Others
4.2 Global 16-Denyprasterone Acetate Sales Value by Application
4.2.1 Global 16-Denyprasterone Acetate Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global 16-Denyprasterone Acetate Sales Value, by Application (2021–2032)
4.2.3 Global 16-Denyprasterone Acetate Sales Value, by Application (%), 2021–2032
4.3 Global 16-Denyprasterone Acetate Sales Volume by Application
4.3.1 Global 16-Denyprasterone Acetate Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global 16-Denyprasterone Acetate Sales Volume, by Application (2021–2032)
4.3.3 Global 16-Denyprasterone Acetate Sales Volume, by Application (%), 2021–2032
4.4 Global 16-Denyprasterone Acetate Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global 16-Denyprasterone Acetate Sales Value by Region
5.1.1 Global 16-Denyprasterone Acetate Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global 16-Denyprasterone Acetate Sales Value by Region (2021–2026)
5.1.3 Global 16-Denyprasterone Acetate Sales Value by Region (2027–2032)
5.1.4 Global 16-Denyprasterone Acetate Sales Value by Region (%), 2021–2032
5.2 Global 16-Denyprasterone Acetate Sales Volume by Region
5.2.1 Global 16-Denyprasterone Acetate Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global 16-Denyprasterone Acetate Sales Volume by Region (2021–2026)
5.2.3 Global 16-Denyprasterone Acetate Sales Volume by Region (2027–2032)
5.2.4 Global 16-Denyprasterone Acetate Sales Volume by Region (%), 2021–2032
5.3 Global 16-Denyprasterone Acetate Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America 16-Denyprasterone Acetate Sales Value, 2021–2032
5.4.2 North America 16-Denyprasterone Acetate Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe 16-Denyprasterone Acetate Sales Value, 2021–2032
5.5.2 Europe 16-Denyprasterone Acetate Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific 16-Denyprasterone Acetate Sales Value, 2021–2032
5.6.2 Asia Pacific 16-Denyprasterone Acetate Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America 16-Denyprasterone Acetate Sales Value, 2021–2032
5.7.2 South America 16-Denyprasterone Acetate Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa 16-Denyprasterone Acetate Sales Value, 2021–2032
5.8.2 Middle East & Africa 16-Denyprasterone Acetate Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 16-Denyprasterone Acetate Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions 16-Denyprasterone Acetate Sales Value and Sales Volume
6.2.1 Key Countries/Regions 16-Denyprasterone Acetate Sales Value, 2021–2032
6.2.2 Key Countries/Regions 16-Denyprasterone Acetate Sales Volume, 2021–2032
6.3 United States
6.3.1 United States 16-Denyprasterone Acetate Sales Value, 2021–2032
6.3.2 United States 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.3.3 United States 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe 16-Denyprasterone Acetate Sales Value, 2021–2032
6.4.2 Europe 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China 16-Denyprasterone Acetate Sales Value, 2021–2032
6.5.2 China 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.5.3 China 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan 16-Denyprasterone Acetate Sales Value, 2021–2032
6.6.2 Japan 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea 16-Denyprasterone Acetate Sales Value, 2021–2032
6.7.2 South Korea 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia 16-Denyprasterone Acetate Sales Value, 2021–2032
6.8.2 Southeast Asia 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India 16-Denyprasterone Acetate Sales Value, 2021–2032
6.9.2 India 16-Denyprasterone Acetate Sales Value by Type (%), 2025 vs 2032
6.9.3 India 16-Denyprasterone Acetate Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Molekula
7.1.1 Molekula Company Information
7.1.2 Molekula Introduction and Business Overview
7.1.3 Molekula 16-Denyprasterone Acetate Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Molekula 16-Denyprasterone Acetate Product Offerings
7.1.5 Molekula Recent Developments
7.2 Hubei Fangtong Pharmaceutical
7.2.1 Hubei Fangtong Pharmaceutical Company Information
7.2.2 Hubei Fangtong Pharmaceutical Introduction and Business Overview
7.2.3 Hubei Fangtong Pharmaceutical 16-Denyprasterone Acetate Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Hubei Fangtong Pharmaceutical 16-Denyprasterone Acetate Product Offerings
7.2.5 Hubei Fangtong Pharmaceutical Recent Developments
7.3 Hubei Dan'ao Pharmaceutical
7.3.1 Hubei Dan'ao Pharmaceutical Company Information
7.3.2 Hubei Dan'ao Pharmaceutical Introduction and Business Overview
7.3.3 Hubei Dan'ao Pharmaceutical 16-Denyprasterone Acetate Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Hubei Dan'ao Pharmaceutical 16-Denyprasterone Acetate Product Offerings
7.3.5 Hubei Dan'ao Pharmaceutical Recent Developments
7.4 Hubei Danjiangkou Kaitai Hormone
7.4.1 Hubei Danjiangkou Kaitai Hormone Company Information
7.4.2 Hubei Danjiangkou Kaitai Hormone Introduction and Business Overview
7.4.3 Hubei Danjiangkou Kaitai Hormone 16-Denyprasterone Acetate Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Hubei Danjiangkou Kaitai Hormone 16-Denyprasterone Acetate Product Offerings
7.4.5 Hubei Danjiangkou Kaitai Hormone Recent Developments
7.5 Hubei Zhuxi Humanwell Pharma
7.5.1 Hubei Zhuxi Humanwell Pharma Company Information
7.5.2 Hubei Zhuxi Humanwell Pharma Introduction and Business Overview
7.5.3 Hubei Zhuxi Humanwell Pharma 16-Denyprasterone Acetate Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Hubei Zhuxi Humanwell Pharma 16-Denyprasterone Acetate Product Offerings
7.5.5 Hubei Zhuxi Humanwell Pharma Recent Developments
7.6 Hubei Minsheng Biopharmaceutical
7.6.1 Hubei Minsheng Biopharmaceutical Company Information
7.6.2 Hubei Minsheng Biopharmaceutical Introduction and Business Overview
7.6.3 Hubei Minsheng Biopharmaceutical 16-Denyprasterone Acetate Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Hubei Minsheng Biopharmaceutical 16-Denyprasterone Acetate Product Offerings
7.6.5 Hubei Minsheng Biopharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 16-Denyprasterone Acetate Industrial Chain
8.2 16-Denyprasterone Acetate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 16-Denyprasterone Acetate Sales Model
8.5.2 Sales Channels
8.5.3 16-Denyprasterone Acetate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global 16-Denyprasterone Acetate market is projected to grow from US$ 72 million in 2025 to US$ 101 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 132
USD 4900.00
(Single User License)
The global 16-Denyprasterone Acetate market size was US$ 72 million in 2025 and is forecast to reach a readjusted size of US$ 101 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 77
USD 4250.00
(Single User License)
The global 16-Denyprasterone Acetate market was valued at US$ 72 million in 2025 and is anticipated to reach US$ 101 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 126
USD 2900.00
(Single User License)
The global market for 16-Denyprasterone Acetate was valued at US$ 69 million in the year 2024 and is projected to reach a revised size of US$ 97 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-05-30
Pages: 93
USD 2900.00
(Single User License)
The global market for 16-Denyprasterone Acetate was estimated to be worth US$ 69 million in 2024 and is forecast to a readjusted size of US$ 97 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 110
USD 3950.00
(Single User License)
The global 16-Denyprasterone Acetate market size was US$ 69 million in 2024 and is forecast to a readjusted size of US$ 97 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 77
USD 4250.00
(Single User License)
The global 16-Denyprasterone Acetate market is projected to grow from US$ 72 million in 2025 to US$ 97 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
Published Date: 2025-05-30
Pages: 143
USD 4900.00
(Single User License)
The global 16-Denyprasterone Acetate market is projected to grow from US$ 72 million in 2025 to US$ 101 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 132
The global 16-Denyprasterone Acetate market size was US$ 72 million in 2025 and is forecast to reach a readjusted size of US$ 101 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 77
The global 16-Denyprasterone Acetate market was valued at US$ 72 million in 2025 and is anticipated to reach US$ 101 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-03-09
Pages: 126
The global market for 16-Denyprasterone Acetate was valued at US$ 69 million in the year 2024 and is projected to reach a revised size of US$ 97 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-05-30
Pages: 93
The global market for 16-Denyprasterone Acetate was estimated to be worth US$ 69 million in 2024 and is forecast to a readjusted size of US$ 97 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 110
The global 16-Denyprasterone Acetate market size was US$ 69 million in 2024 and is forecast to a readjusted size of US$ 97 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 77
The global 16-Denyprasterone Acetate market is projected to grow from US$ 72 million in 2025 to US$ 97 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
Published: 2025-05-30
Pages: 143
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now